Welcome to Inventiva Pharma

No front page content has been created yet.


Latest News

Inventiva’s lanifibranor found to have good safety profile following first assessment of carcinogenicity studies’ results
Inventiva to Present the Latest Findings in its RORγ program at the 256th National Meeting of the American Chemical Society
Inventiva Announces Poster Presentation on a Promising Biomarker for MPS VI at the 15th International Symposium on MPS and Related Diseases